Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 30 June 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,160,353 2.74% 116,090 0.15% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 170,400 0.22% 52,700 0.07% agreements to purchase/sell Total 2,330,753 2.96% 168,790 0.21% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 1,383 35.4798 USD Purchase 1,122 35.11605615 Purchase 946 35.5800 USD Purchase 400 35.6742 Purchase 100 35.67 Purchase 100 35.8 Purchase 1,119 35.5800 USD Purchase 100 35.77 Purchase 350 35.62871429 Purchase 100 35.71 Purchase 1,203 35.5800 USD Purchase 1,203 35.4983 USD Purchase 530 35.5800 USD Purchase 1,383 35.5800 USD Purchase 708 35.5800 USD Purchase 12 35.5800 USD Purchase 2,389 35.5800 USD Purchase 5,269 35.5800 USD Purchase 7,479 35.5800 USD Purchase 50 35.4635 Purchase 238 35.58 Purchase 300 35.596 Purchase 100 35.456 Purchase 3,540 35.58 Purchase 1,600 35.4536 Purchase 600 35.456 Purchase 1,368 35.5800 USD Purchase 1,635 35.50948012 Purchase 200 35.68375 Purchase 100 35.455 Purchase 200 35.535 Purchase 300 35.57133333 Purchase 56 35.5800 USD Purchase 500 35.5230 USD Purchase 300 35.48 Purchase 300 35.51 Purchase 360 35.355 Purchase 700 35.40714286 Purchase 305 35.48885246 Purchase 106 35.5800 USD Purchase 129 35.5800 USD Purchase 130 35.5800 USD Purchase 13,000 35.4469 Purchase 189 35.5800 USD Purchase 499 35.5800 USD Purchase 100 35.17 Purchase 637 35.65610675 Sale 44 35.5800 USD Sale 53 35.5800 USD Sale 22 35.5800 USD Sale 2,389 35.5800 USD Sale 1,454 35.5800 USD Sale 77 35.5800 USD Sale 1,000 35.5800 USD Sale 84 35.5800 USD Sale 1,224 35.5800 USD Sale 1,203 35.5800 USD Sale 200 35.5638 USD Sale 600 35.5638 USD Sale 1,383 35.5800 USD Sale 1,600 35.4536 Sale 3,143 35.41790964 Sale 1,267 35.42980268 Sale 900 35.45777778 Sale 3,000 35.43950333 Sale 190 35.41473684 Sale 300 35.48 Sale 637 35.65610675 Sale 600 35.456 Sale 100 35.67 Sale 100 35.75 Sale 1,122 35.11605615 Sale 100 35.455 Sale 200 35.535 Sale 100 35.17 Sale 600 35.495 Sale 100 35.456 Sale 400 35.735 Sale 300 35.58 Sale 2,750 35.48647818 Sale 300 35.596 Sale 3,240 35.58 Sale 200 35.69 Sale 300 35.5713 Sale 3,300 35.4530303 Sale 200 35.735 Sale 900 35.55855556 Sale 200 35.67 Sale 100 35.69 Sale 300 35.68666667 Sale 50 35.4635 Sale 400 35.6742 Sale 200 35.735 Sale 238 35.58 Sale 600 35.7424 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 01 July 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased 100 25.0000 AMER 20/02/2010 Option Purchased 100 22.5000 AMER 22/01/2011 Option Purchased 100 17.5000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased 100 12.5000 AMER 22/01/2011 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased -200 35.0000 AMER 21/11/2009 Option Purchased -23,900 25.0000 AMER 22/08/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased -700 35.0000 AMER 18/07/2009 Option Purchased -1,000 30.0000 AMER 18/07/2009 Option Purchased -1,200 30.0000 AMER 22/01/2011 Option Purchased -1,600 30.0000 AMER 21/11/2009 Option Purchased -2,000 40.0000 AMER 18/07/2009 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -2,400 25.0000 AMER 16/01/2010 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -11,100 30.0000 AMER 18/07/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 1,900 30.0000 AMER 22/08/2009 Option Purchased 22,300 25.0000 AMER 22/08/2009 Option Purchased 8,000 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 6,000 40.0000 AMER 22/08/2009 Option Purchased 4,400 35.0000 AMER 16/01/2010 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased 2,900 35.0000 AMER 21/11/2009 Option Purchased 2,700 50.0000 AMER 16/01/2010 Option Purchased 100 35.0000 AMER 22/08/2009 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 200 15.0000 AMER 22/01/2011 Option Purchased 1,800 40.0000 AMER 22/01/2011 Option Purchased 1,700 30.0000 AMER 22/08/2009 Option Purchased 1,200 40.0000 AMER 21/11/2009 Option Purchased 1,100 35.0000 AMER 18/07/2009 Option Purchased 1,100 30.0000 AMER 21/11/2009 Option Purchased 1,000 55.0000 AMER 22/01/2011 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 900 22.5000 AMER 22/08/2009 Option Purchased 700 35.0000 AMER 16/01/2010 Option Purchased 87,900 35.0000 AMER 22/08/2009 Option Purchased 2,700 45.0000 AMER 21/11/2009 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings